The Global Obesity War: Novo Nordisk's Next Battleground The pharmaceutical industry is poised for a significant shift as weight loss medications become increasingly globalized.
Novo Nordisk, a leading player in the space, plans to launch its Wegovy pill outside of the US later this year. This move marks a crucial turning point in the battle for dominance of the weight loss market.
Wegovy's success in the US has been remarkable, with over 2 million prescriptions already issued and sales far exceeding expectations despite a lower price point than injectable equivalents.